Temple Health Chest Initiative (THCI 2.0)

计划入组 1,000 人 · 首次发布于 2025 年 4 月 18 日

Building a Healthy Temple: a Diabetes Self-management Support Program in Hispanic Faith Community Settings

计划入组 360 人 · 首次发布于 2019 年 5 月 2 日

JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population

计划入组 168 人 · 首次发布于 2021 年 5 月 18 日

CD59 Inhibitors (Temple University)

rHCG (Unico Health)

rFSH (Unico Health)

Temple University Children's Medical Center

United States

Temple Therapeutics BV

Netherlands

Temple Industrial Welding Supply Co

United States

Checkpoint Inhibitor Use Surges Following FDA Approval for Gastroesophageal Cancer Treatment

Fox Chase Trial Explores Active Surveillance for Muscle-Invasive Bladder Cancer

OncoDaily Medical Journal Expands Editorial Board with 20 Oncology Specialists Across 12 Countries